Regeneron

98 email addresses found for regeneron.com
{f}.{last}@regeneron.com
98 email addresses
3 sources
http://cancerres.aacrjournals.org/content/early/2012/11/10/0008-5472.can-12-2064 September 9, 2017
http://mct.aacrjournals.org/content/early/2014/03/14/1535-7163.mct-13-1033 March 3, 2018
http://tarrytownroundup.blogspot.com/2016/06 October 10, 2017
3 sources
http://amcp.org/dynamicroster.aspx September 9, 2017
http://my.amcp.org/dynamicroster.aspx September 9, 2017
http://prod.amcp.org/dynamicroster.aspx September 9, 2017
9 sources
http://biorxiv.org/content/early/2017/01/06/098574 September 9, 2017
http://biorxiv.org/content/early/2017/01/09/098574 July 7, 2017
http://psb.stanford.edu/callfor/papers/cfp-drug October 10, 2017
http://science.sciencemag.org/content/354/6319/aaf6814 November 11, 2017
http://science.sciencemag.org/content/354/6319/aaf6814.long December 12, 2017
http://sergiostagnaro.wordpress.com/2016/03/03/tu-quoque-nejm-per-sconfiggere-la-cardiopatia-ischemica-bisogna-studiare-il-reale-rischio-congenito-di-cad September 9, 2017
http://sergiostagnaro.wordpress.com/tag/cad September 9, 2017
http://sergiostagnaro.wordpress.com/tag/cad-inherited-real-risk September 9, 2017
http://sergiostagnaro.wordpress.com/tag/teoria-microcircolatoria-dellarteriosclerosi October 10, 2017
3 sources
http://d3g4wvckj8gu7k.cloudfront.net/content/early/2017/04/07/1535-7163.mct-16-0839 May 5, 2017
http://mct.aacrjournals.org/content/16/7/1299 October 10, 2017
http://mct.aacrjournals.org/content/early/2017/04/07/1535-7163.mct-16-0839 October 10, 2017
5 sources
http://bio-protocol.org/cn/e1947 October 10, 2017
http://bio-protocol.org/e1947 May 5, 2017
http://cancerres.aacrjournals.org/content/75/19/4086 October 10, 2017
http://cancerres.aacrjournals.org/content/early/2015/09/11/0008-5472.can-14-3773 September 9, 2017
http://cancerres.aacrjournals.org/content/early/2015/09/17/0008-5472.can-14-3773 September 9, 2017
8 sources
http://biorxiv.org/content/early/2017/01/06/098574 September 9, 2017
http://biorxiv.org/content/early/2017/01/09/098574 July 7, 2017
http://biorxiv.org/content/early/2017/03/22/119461 September 9, 2017
http://science.gov/topicpages/a/algorithm+called+fast.html March 3, 2017
http://science.gov/topicpages/c/common+tlr4+variants.html December 12, 2016
http://science.gov/topicpages/c/copy+number+amplification.html March 3, 2017
http://science.gov/topicpages/n/novo+copy+number.html November 11, 2016
http://science.gov/topicpages/r/regulatory+sequence+common.html November 11, 2016
8 sources
http://cancerres.aacrjournals.org/content/76/8/2327 December 12, 2017
http://cancerres.aacrjournals.org/content/early/2016/02/26/0008-5472.can-15-1443 October 10, 2017
http://cancerres.aacrjournals.org/content/early/2016/03/02/0008-5472.can-15-1443 November 11, 2017
http://mct.aacrjournals.org/content/16/5/861 September 9, 2017
http://mct.aacrjournals.org/content/early/2017/03/04/1535-7163.mct-16-0665 July 7, 2017
http://mct.aacrjournals.org/content/early/2017/04/16/1535-7163.mct-16-0665 October 10, 2017
http://ncbi.nlm.nih.gov/pubmed/15293563 January 1, 2015
http://researchsea.com/html/article.php/aid/1209/cid/3 December 12, 2015
20+ sources
http://benzinga.com/pressreleases/14/08/n4755431/regeneron-reports-second-quarter-2014-financial-and-operating-results November 11, 2016
http://bio-medicine.org/biology-technology-1/regeneron-and-sanofi-announce-plan-to-use-priority-review-voucher-for-alirocumab-u-s--fda-submission-29759-1 April 4, 2016
http://bio-medicine.org/biology-technology-1/regeneron-to-report-second-quarter-2014-financial-and-operating-results-and-host-conference-call-and-webcast-on-august-5--2014-29571-1 January 1, 2015
http://bio-medicine.org/medicine-technology-1/regeneron-and-sanofi-to-present-results-from-four-phase-3-alirocumab-trials-in-hot-line-session-at-esc-congress-2014-39446-1 April 4, 2016
http://biospace.com/news/regeneron-pharmaceuticals-inc-announces-winners-of/335722 January 1, 2015
http://biospace.com/News/regeneron-pharmaceuticals-inc-announces-winners-of/335722 April 4, 2015
http://biospace.com/news_story.aspx May 5, 2015
http://earningswhispers.com/epsdetails/regn September 9, 2017
http://freshnews.com/regeneron-and-teva-provide-update-on-fasinumab-clinical-development-programs/20161017 October 10, 2016
http://globenewswire.com/news-release/2014/07/09/649763/10088795/en/sanofi-and-regeneron-announce-positive-results-from-phase-2b-study-of-dupilumab-in-patients-with-moderate-to-severe-atopic-dermatitis.html January 1, 2015
http://health-fitness.news-articles.net/content/regeneron-announces-upcoming-investor-conference-presentation.xhtml November 11, 2016
http://mediaroom.sanofi.com/sanofi-and-regeneron-announce-new-positive-praluent-alirocumab-phase-3-data-presented-at-esc-congress-2015-2 May 5, 2017
http://mediaroom.sanofi.com/sanofi-et-regeneron-annoncent-lapprobation-de-praluent-alirocumab-dans-lunion-europeenne-pour-le-traitement-de-lhypercholesterolemie-2 May 5, 2017
http://mediaroom.sanofi.com/sanofi-et-regeneron-prevoient-dutiliser-un-droit-dacces-a-un-examen-prioritaire-pour-la-demande-dapprobation-dalirocumab-aupres-de-la-fda-des-etats-unis-2 May 5, 2017
http://mediaroom.sanofi.com/sanofi-sanofi-and-regeneron-announce-positive-results-from-phase-2b-study-of-dupilumab-in-patients-with-moderate-to-severe-atopic-dermatitis-2 June 6, 2017
http://mediaroom.sanofi.com/sanofi-sanofi-and-regeneron-announce-start-of-phase-3-study-of-dupilumab-in-patients-with-atopic-dermatitis-2 August 8, 2017
http://medindia.net/health-press-release/tony-coles-md-elected-to-regeneron-board-of-directors-315256-1.htm August 8, 2017
http://newswire.ca/fr/news-releases/sanofi-et-regeneron-annoncent-la-presentation-de-nouvelles-donnees-positives-de-phase-3-de-praluent-alirocumab-au-congres-2015-de-lesc-523636321.html September 9, 2017
http://newswire.ca/news-releases/sanofi-and-regeneron-announce-new-positive-praluent-alirocumab-phase-3-data-presented-at-esc-congress-2015-523635111.html September 9, 2017
http://pharmafocusasia.com/pressreleases/regeneron-announces-upcoming-2015-investor-conference-presentations January 1, 2016
http://prnewswire.com/news-releases/regeneron-and-sanofi-announce-presentation-of-detailed-positive-results-from-four-pivotal-alirocumab-trials-at-esc-congress-2014-273358761.html May 5, 2015
http://prnewswire.com/news-releases/regeneron-and-sanofi-to-present-results-from-four-phase-3-alirocumab-trials-in-hot-line-session-at-esc-congress-2014-272525111.html April 4, 2015
http://prnewswire.com/news-releases/regeneron-announces-upcoming-2014-investor-conference-presentations-271835731.html July 7, 2015
http://prnewswire.com/news-releases/regeneron-announces-update-to-upcoming-2014-investor-conference-presentations-261291521.html April 4, 2015
http://prnewswire.com/news-releases/regeneron-reports-second-quarter-2014-financial-and-operating-results-269955161.html May 5, 2015
http://sanoficanada.fr.mediaroom.com/2015-09-01-sanofi-et-regeneron-annoncent-la-pr-sentation-de-nouvelles-donn-es-positives-de-phase-3-de-praluent-alirocumab-au-congr-s-2015-de-lesc November 11, 2016
http://sanoficanada.mediaroom.com/2015-09-01-sanofi-and-regeneron-announce-new-positive-praluent-alirocumab-phase-3-data-presented-at-esc-congress-2015 June 6, 2016
http://streetinsider.com/press+releases/regeneron+announces+presentation+at+the+25th+annual+credit+suisse+healthcare+conference/12154305.html October 10, 2016
http://thestreet.com/story/12769643/1/sanofi-and-regeneron-announce-positive-results-from-phase-2b-study-of-dupilumab-in-patients-with-moderate-to-severe-atopic-dermatitis.html November 11, 2016
http://thestreet.com/story/12849993/1/regeneron-pharmaceuticals-inc-nasdaq-regn-to-ring-the-nasdaq-stock-market-opening-bell.html January 1, 2015
20+ sources
http://acnnewswire.rssing.com/chan-39994335/all_p206.html April 4, 2018
http://asianhhm.com/pressreleases/regeneron-and-sanofi-announce-approval-of-praluent-alirocumab-for-the-treatment-of-hypercholesterolemia-in-the-european-union March 3, 2016
http://asianhhm.com/prnews/regeneron-and-sanofi-announce-approval-of-praluent-alirocumab-for-the-treatment-of-hypercholesterolemia-in-the-european-union March 3, 2016
http://benzinga.com/pressreleases/12/11/n3097699/zaltrap-ziv-aflibercept-receives-chmp-positive-opinion-in-the-european- August 8, 2015
http://bio-medicine.org/biology-technology-1/regeneron-and-sanofi-announce-plan-to-use-priority-review-voucher-for-alirocumab-u-s--fda-submission-29759-1 February 2, 2018
http://bio-medicine.org/biology-technology-1/regeneron-to-report-second-quarter-2014-financial-and-operating-results-and-host-conference-call-and-webcast-on-august-5--2014-29571-1 May 5, 2017
http://bio-medicine.org/medicine-technology-1/regeneron-announces-upcoming-2013-investor-conference-presentation-37394-1 January 1, 2015
http://bio-medicine.org/medicine-technology-1/sanofi-and-regeneron-report-positive-results-with-sarilumab-in-first-phase-3-rheumatoid-arthritis-registration-trial-37118-1 March 3, 2016
http://biospace.com/news/fda-advisers-reject-regeneron-pharmaceuticals-inc/259466 January 1, 2015
http://biospace.com/news_print.aspx July 7, 2015
http://biospace.com/news/sanofi-france-and-regeneron-pharmaceuticals-inc/319187 March 3, 2016
http://biospace.com/news_story.aspx April 4, 2015
http://drugs.com/nda/zaltrap_120405.html April 4, 2015
http://fiercebiotech.com/biotech/regeneron-and-sanofi-announce-sarilumab-biologics-license-application-accepted-for-review May 5, 2017
http://investor.regeneron.com/releasedetail.cfm May 5, 2015
http://mediaroom.sanofi.com/sanofi-and-regeneron-announce-fda-approval-of-dupixent-dupilumab-the-first-targeted-biologic-therapy-for-adults-with-moderate-to-severe-atopic-dermatitis April 4, 2018
http://medindia.net/health-press-release/displaynews.asp August 8, 2017
http://multivu.com/mnr/57253-sanofi-fda-approves-zaltrap-ziv-aflibercept March 3, 2016
http://news.genzyme.com/press-release/sanofi-and-regeneron-announce-publication-positive-phase-2-dupilumab-data-journal-amer February 2, 2016
http://news.genzyme.com/print/node/3244 February 2, 2016
http://newsroom.regeneron.com/releasedetail.cfm April 4, 2015
http://pharmafocusasia.com/pressreleases/regeneron-announces-eu-approval-of-eylea-aflibercept-injection-for-the-treatment-of-visual-impairment-secondary-to-myopic-choroidal-neovascularization January 1, 2016
http://prnewswire.com/news-releases/eylea-aflibercept-injection-recommended-for-approval-for-the-treatment-of-visual-impairment-due-to-diabetic-macular-edema-in-the-european-union-264880011.html May 5, 2015
http://prnewswire.com/news-releases/regeneron-highlights-eylea-aflibercept-injection-data-to-be-presented-at-american-academy-of-ophthalmology-annual-meeting-231629281.html January 1, 2015
http://prnewswire.com/news-releases/regeneron-named-top-employer-in-the-global-biopharmaceutical-industry-for-the-second-year-in-a-row-229144571.html April 4, 2015
http://prnewswire.com/news-releases/regeneron-reports-second-quarter-2014-financial-and-operating-results-269955161.html May 5, 2015
http://prnewswire.com/news-releases/sanofi-and-regeneron-to-present-alirocumab-clinical-data-at-the-american-college-of-cardiologys-63rd-annual-scientific-session-252586521.html May 5, 2015
http://sec.gov/archives/edgar/data/872589/000153217614000034/exhibit991q22014.htm August 8, 2015
http://thestreet.com/story/12040321/1/regeneron-to-present-phase-3-data-for-eylea-aflibercept-injection-in-diabetic-macular-edema-at-upcoming-retina-society-meeting.html May 5, 2017
http://wallstreet-online.de/nachricht/8243085-sanofi-and-regeneron-announce-sarilumab-biologics-license-application-accepted-for-review-by-us-fda May 5, 2017
5 sources
http://genomeweb.com/resources/jobs/associate-managermanager-clinical-biostatistics-and-epidemiology March 3, 2017
http://genomeweb.com/resources/jobs/colony-manager May 5, 2017
http://genomeweb.com/resources/jobs/scientiststaff-scientistassociate-manager-translational-genetics May 5, 2017
http://genomeweb.com/resources/jobs/staff-scientistmanager-clinical-informatics March 3, 2017
http://genomeweb.com/resources/jobs/staff-scientist-moleculartransgenic-biology May 5, 2017
Show more results
88 more results for regeneron.com. Sign up or log in to access the full and uncovered results.

Add the leading solution to find professional email addresses to your toolkit.

Hunter is already trusted by more than 1,000,000 professionals to build more connections and grow their business. Start today and get 100 free searches/month..

Google
IBM
Microsoft
Shopify
Adobe
Oracle

More information about regeneron.com

Industry: Science

Language of the website: English

Main technologies used:

Related companies

Broad Institute
broadinstitute.org • 640 email addresses
Usgs
usgs.gov • 7478 email addresses
Hagley
hagley.org • 102 email addresses
Smithsonian Institution
si.edu • 3091 email addresses
The University Of Chicago
uchicago.edu • 10397 email addresses
American Astronomical Society
aas.org • 212 email addresses
Med Immune
medimmune.com • 170 email addresses
Whitney Stories
whitney.org • 102 email addresses
image/svg+xml

Hunter is the leading solution to find and verify professional email addresses. Search any domain name to find instantly the main email format used in an organization and all the email addresses publicly available on the web.

Discover Hunter

  1. Homepage
  2. Companies directory
  3. Science
  4. Regeneron